Antibody Drug Conjugate

Therapeutic Antibody conjugates proven clinically effective with acceptable toxicity

Antibody Drug Conjugates (ADCs) have shown a clearly documented efficacy and acceptable toxicity and can be easily implemented in oncology departments where chemotherapy administration is a routine practice. A similar efficacy with acceptable toxicity has been documented with Antibody Radionuclide Conjugates (ARCs) which need to be injected with the help of a nuclear medicine department …

Therapeutic Antibody conjugates proven clinically effective with acceptable toxicity Read More »

Research shows tumor-targeted radiosensitization using antibody drug conjugates may redues toxicity and improve outcome

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects. In a paper published in Nature …

Research shows tumor-targeted radiosensitization using antibody drug conjugates may redues toxicity and improve outcome Read More »